Physician profile
Yang Shen
NPI 1043455595
$8,346.84
in general payments reported to CMS, 2019-2025
36 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,258 · 2020: $670 · 2021: $770 · 2022: $521 · 2023: $1,155 · 2024: $1,434 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,819 · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,819.10 |
| Education | $308.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,011.63 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $1,577.08 | 2019-2025 | Tremfya, Remicade, Stelara |
| Genzyme Corporation | $599.69 | 2019-2025 | |
| Galderma Laboratories, L.P. | $487.59 | 2019-2025 | Nemluvio, Oracea, Epsolay |
| Lilly USA, LLC | $456.69 | 2019-2025 | Ebglyss, Taltz |
| Regeneron Healthcare Solutions, INC. | $387.21 | 2021-2025 | Libtayo, Dupixent |
| Dermavant Sciences, INC. | $287.78 | 2022-2024 | Vtama |
| Ucb, INC. | $277.87 | 2019-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $254.23 | 2019-2024 | |
| Genentech USA, INC. | $249.06 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $234.43 | 2022-2025 | Sotyktu |
| Pfizer INC. | $202.52 | 2021-2025 | |
| Prugen, INC. Pharmaceuticals | $147.68 | 2019 | |
| Amgen INC. | $127.96 | 2020-2025 | Otezla |
| Vyne Pharmaceuticals INC. | $111.63 | 2020-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $96.40 | 2019 | |
| Leo Pharma INC. | $92.89 | 2019-2022 | |
| Journey Medical Corporation | $92.14 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $89.71 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $89.50 | 2019-2025 | |
| Organon LLC | $83.21 | 2025 | Vtama |
| Incyte Corporation | $62.41 | 2021-2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.40 | 2024 | Spevigo |
| Almirall LLC | $37.20 | 2019-2023 | Klisyri |
| Verrica Pharmaceuticals INC. | $34.89 | 2024-2025 | Ycanth |
| Melinta Therapeutics, LLC | $29.53 | 2019 | |
| Botanix Sb INC | $22.53 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.60 | 2024 | Cabtreo |
| Kyowa Kirin, INC. | $21.36 | 2025 | |
| Biofrontera INC. | $19.68 | 2021 | |
| Merck Sharp & Dohme LLC | $18.02 | 2019 | |
| Aclaris Therapeutics, INC. | $15.74 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.65 | 2022 | |
| Dermira, INC. | $14.03 | 2021 | |
| Celgene Corporation | $13.36 | 2019 | |
| Encore Dermatology INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yang Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.